Short-chain fatty acids (SCFAs)—especially acetate, propionate, and butyrate—are produced when gut microbes ferment carbohydrates that the human body cannot digest. Over the past decade, these small molecules have moved beyond being viewed as simple fuel. Instead, they are now recognized as signalling messengers that help tune metabolism, shape immune responses, and support physiological balance across organs. A new review in Nature Metabolism brings together scattered findings to clarify how SCFAs are made, how they are processed in the body, and why they matter for health.
The article emphasizes that SCFA production is not uniform. It depends on which microbial communities inhabit the gut, which dietary substrates reach the colon, and how microbes share resources through cross-feeding. When multiple bacterial species coordinate, fermentation pathways can shift, increasing the output of particular SCFAs. In that way, the “hardware” of the microbiome and the “inputs” provided by diet jointly determine the chemical signals generated in the intestine.
After their formation, SCFAs are handled by host tissues through absorption and further metabolic conversion. The review highlights that acetate, propionate, and butyrate can influence local and systemic physiology, helping link intestinal chemistry to whole-body regulation. Their effects are therefore both immediate—through signalling pathways—and longer-lasting—through changes in gene regulation.
Mechanistically, the authors focus on receptor-mediated communication. SCFAs activate specific receptors on immune and metabolic cells, altering inflammatory tone and metabolic signalling. This receptor layer helps explain how intestinal events can reverberate in distant tissues that rely on tightly controlled energy and immune states.
Beyond receptors, SCFAs also affect epigenetics. By influencing chromatin-modifying enzymes and related regulatory networks, they can change how genes are expressed without altering DNA sequence. Such effects provide a plausible bridge between diet–microbiome interactions and sustained shifts in health trajectories.
The review further surveys tissue-specific outcomes, from effects on gut barrier function to immune regulation and metabolic homeostasis. Importantly, this heterogeneity helps reconcile why SCFAs sometimes show protective associations while other contexts yield mixed results—differences in dose, timing, microbial ecology, and host physiology can all matter.
When the evidence is assembled, the paper argues that SCFAs are strongly implicated in metabolic health and disease risk. Conditions such as obesity, insulin dysregulation, and inflammatory disorders have been linked to altered SCFA profiles, though causality remains an active area of investigation. The authors also discuss the limitations of current studies, including differences in measurement methods and confounding dietary factors.
Finally, the review evaluates translational opportunities. Rather than treating SCFAs as isolated supplements, it frames dietary and therapeutic strategies around pathways that enhance beneficial SCFA production or mimic their downstream effects. With low fibre intake becoming a public health concern worldwide, the work positions SCFAs as a key biological rationale for improving diet quality.
Overall, this Nature Metabolism review synthesizes what is known—and what is still uncertain—about SCFAs as central mediators between gut microbes and host biology. It suggests that targeting microbial fermentation and SCFA signalling could become a practical lever for metabolic disease prevention.
Subject of Research: Gut microbiota–derived short-chain fatty acids and their physiological roles
Article Title: Short-chain fatty acids
Article References: Dagbasi, A., Cai, M., Hirdaramani, A. et al. Short-chain fatty acids. Nat Metab (2026). https://doi.org/10.1038/s42255-026-01579-9
DOI: https://doi.org/10.1038/s42255-026-01579-9
Image Credits: AI Generated
Tags: dietary influences on SCFA productioneffects of SCFAs on metabolic regulationgut microbiome metabolitesgut-brain axis and systemic healthmicrobial cross-feeding in the colonmicrobiome diversity and health outcomesmicrobiome fermentation pathwaysrole of SCFAs in maintaining physiological balanceSCFA absorption and metabolismSCFA impact on organ functionSCFA signaling and immune modulationshort-chain fatty acids
